Minerva Neuroscie (NERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,082 | -18,642 | -12,703 | -6,093 | -56,901 |
| Depreciation Amortization | 642 | 450 | 223 | 77 | 1,986 |
| Accounts payable and accrued liabilities | 719 | 93 | -78 | 255 | 369 |
| Other Working Capital | -32 | -985 | -342 | 771 | 998 |
| Other Operating Activity | 1,483 | 1,418 | 960 | 82 | 17,588 |
| Operating Cash Flow | $-24,269 | $-17,667 | $-11,940 | $-4,909 | $-35,961 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -18,285 | -22,335 | -23,163 | N/A | N/A |
| PPE Investments | N/A | N/A | N/A | N/A | -46 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 1,168 |
| Other Investing Activity | -45 | -45 | -45 | -5 | -35 |
| Investing Cash Flow | $-18,330 | $-22,380 | $-23,208 | $-5 | $1,087 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,000 | 10,000 | 10,000 | 10,000 | 1,883 |
| Debt Repayment | N/A | N/A | N/A | N/A | -1,883 |
| Common Stock Issued | 31,000 | 31,000 | 31,000 | 31,000 | 55,041 |
| Other Financing Activity | -2,663 | -2,663 | -2,663 | -2,430 | -3,440 |
| Financing Cash Flow | $38,337 | $38,337 | $38,337 | $38,570 | $51,601 |
| Beginning Cash Position | 18,546 | 18,546 | 18,546 | 18,546 | 1,818 |
| End Cash Position | 14,284 | 16,837 | 21,736 | 52,201 | 18,546 |
| Net Cash Flow | $-4,262 | $-1,709 | $3,190 | $33,655 | $16,727 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,269 | -17,667 | -11,940 | -4,909 | -35,961 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -46 |
| Free Cash Flow | -24,269 | -17,667 | -11,940 | -4,909 | -36,007 |